#100000
A First Class stamp <a href=" http://weimar.edu/written-papers/ ">writing page</a> Aegerion, which received a positive opinion for the drug from the European Committee for Medicinal Products for Human Use in May, said it now expects a formal marketing approval in August. A CHMP nod increases the likelihood of an approval in European Union.
